Sign in Subscribe
Universities and colleges

Human Papillomavirus Plays a Significant Role in Head and Neck Cancer

Strategic Insights

— 1 min read

Human papillomavirus (HPV) has been identified as a major risk factor for head and neck squamous cell carcinoma (HNSCC), accounting for 20 to 25% of cases worldwide. Specifically, HPV has been found to be etiologically associated with cancers in the oropharynx. The virus causes cancer by expressing two oncoproteins, E6 and E7, which disrupt the function of tumor suppressor proteins, leading to genetic instability. Research has shown that HPV-positive cancers are clinically distinct from HPV-negative cancers, with better treatment responses and survival outcomes. The findings of this study have significant implications for disease prevention, patient care, and surveillance strategies for HNSCC patients.

Key Takeaways:

  • HPV is responsible for 20 to 25% of head and neck squamous cell carcinoma (HNSCC) cases worldwide.
  • The virus has been found to be etiologically associated with cancers in the oropharynx.
  • HPV causes cancer by expressing two oncoproteins, E6 and E7, which disrupt the function of tumor suppressor proteins, leading to genetic instability.
  • HPV-positive cancers are clinically distinct from HPV-negative cancers, with better treatment responses and survival outcomes.
  • Tumor HPV-positivity is a favorable prognostic biomarker for HNSCC patients.
  • Further understanding of carcinogenesis and clinical behavior of HPV-positive cancers can improve disease prevention, patient care, and surveillance strategies for HNSCC patients.
  • C.H. Chung and colleagues published a study in Clinical Cancer Research in 2009, highlighting the role of HPV in pathogenesis and clinical implications of HNSCC.
  • The study concluded that expression of E6 and E7 alone is not sufficient for cellular transformation, and additional genetic alterations are necessary for malignant progression in the setting of virus-induced genomic instability.

Statistics:

  • Annual incidence of HNSCC worldwide: approximately 400,000.
  • Percentage of HNSCC cases attributed to HPV: 20 to 25%.
  • Percentage of oropharynx cancers associated with HPV: majority (no specific percentage given).

Sources:

  • Chung, C.H. et al. (2009). Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications. Clinical Cancer Research, 15(22), 6758-6762.
  • American Association of Cancer Research. (Publisher contact information: 615 Chestnut St., 17TH Floor, Philadelphia, PA 19106-4404, USA).

Read more